Insider · CIK 0002083206
Louis Edward Tamayo
Files at LXEO (Lexeo Therapeutics, Inc.). First filing -, latest -.
Louis Edward Tamayo files SEC Form 4 as CFO at LXEO (Lexeo Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Louis Edward Tamayo has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +54,750 | $0.00 | $0 | 54,750 | 15 d ago |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +44,665 | $0.00 | $0 | 89,665 | Feb 6, 2026 |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +226,665 | $0.00 | $0 | 226,665 | Feb 6, 2026 |
| Aug 29, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 45,000 | Sep 3, 2025 |
| Aug 29, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +280,000 | $0.00 | $0 | 280,000 | Sep 3, 2025 |
Questions about Louis Edward Tamayo
Answered from the filings on this page, as of the latest one.
Is Louis Edward Tamayo buying or selling?
Louis Edward Tamayo has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Louis Edward Tamayo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Louis Edward Tamayo has 0.
Where does Louis Edward Tamayo file Form 4?
Louis Edward Tamayo has filed Form 4 at LXEO (Lexeo Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.